GlyCardial Diagnostics
Barcelona
About GlyCardial Diagnostics
GlyCardial Diagnostics is a spin-off company of the Catalan Institute of Cardiovascular Sciences (ICCC) and the Spanish National Research Council (CSIC) focused on the development of a novel in vitro diagnostic device for myocardial ischemia. The technology is based on the detection of Apo J-Glyc in blood as a biomarker for the early diagnosis of cardiac ischemia and the prediction of patient’s evolution after an ischemic event.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.1M
- Funding stage: Early Stage Venture
- Last round: Grant (Jan 2019)
- Website: glycardial.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Life Science, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/glycardial-diagnostics-13136 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.